Literature DB >> 19169364

Multiple assessment in quality of life trials: how many questionnaires? How often should they be given?

Andrew J Vickers1.   

Abstract

Researchers conducting randomized trials of integrative interventions often ask patients to complete multiple different quality of life questionnaires or symptom severity scales repeatedly over the course of a trial. Although trialists rarely if ever give a strong justification for either the number of questionnaires they give or how often they give them, these are design decisions that can be taken systematically. Giving large numbers of questionnaires can improve the precision of trial results, and provide interesting secondary data, such as on the time course of symptoms. However, doing so can also lead to excessive patient drop-out, an undue data management burden and difficulties with interpretation of results. As a general guideline, each aspect of quality of life should be measured by a single questionnaire, and researchers should avoid giving more than three different questionnaires to patients. Decisions about the appropriate number of assessments to use can be based on statistical properties derived from simple formulae.

Entities:  

Mesh:

Year:  2006        PMID: 19169364      PMCID: PMC2629590          DOI: 10.2310/7200.2006.017

Source DB:  PubMed          Journal:  J Soc Integr Oncol        ISSN: 1715-894X


  3 in total

1.  Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design.

Authors:  L Frison; S J Pocock
Journal:  Stat Med       Date:  1992-09-30       Impact factor: 2.373

2.  How to measure quality of life in integrative oncology research.

Authors:  Andrew J Vickers
Journal:  J Soc Integr Oncol       Date:  2006

3.  How many repeated measures in repeated measures designs? Statistical issues for comparative trials.

Authors:  Andrew J Vickers
Journal:  BMC Med Res Methodol       Date:  2003-10-27       Impact factor: 4.615

  3 in total
  3 in total

Review 1.  Which botanicals or other unconventional anticancer agents should we take to clinical trial?

Authors:  Andrew J Vickers
Journal:  J Soc Integr Oncol       Date:  2007

Review 2.  Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials.

Authors:  Joseph M Unger; Riha Vaidya; John L Gore
Journal:  Urol Oncol       Date:  2018-03-21       Impact factor: 3.498

3.  How to improve accrual to clinical trials of symptom control 2: design issues.

Authors:  Andrew J Vickers
Journal:  J Soc Integr Oncol       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.